Hong Kong develops first anti-COVID-19 stainless steel

A team of researchers at the Department of Mechanical Engineering of the Faculty of Engineering of the University of Hon...

December 23, 2021 | Thursday | News
Australia updates COVID-19 calculator for Pfizer vaccine efficacy

The University of Queensland in Australia has updated a calculator to help people understand their risk factors for COVI...

December 22, 2021 | Wednesday | News
Any New Way to Track Omicron Besides the Sequencing?

  WHO has officially appealed to countries that they must enhance surveillance & sequencing efforts to curb Om...

December 16, 2021 | Thursday | News
Fapon Biotech Introduces POCT Test Solution for SARS-CoV-2 Omicron Variant Identification

Omicron variant has showed surging cases in nearly 77 countries around the world in less than one month and seems to bec...

December 15, 2021 | Wednesday | News
Singapore extends use of Pfizer vaccine for children of age 5 to 11

The Health Sciences Authority (HSA) in Singapore has extended the authorisation of Comirnaty COVID-19 vaccine by Pfizer-...

December 13, 2021 | Monday | News
Hong Kong studies impact of Pfizer vaccine on Omicron variant

A recent study jointly conducted by the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and the Faculty of...

December 13, 2021 | Monday | News
$540 M to continue and expand Australia’s COVID-19 response

The Australian government has invested a further $540 million in response to the COVID-19 pandemic including significant...

December 8, 2021 | Wednesday | News
Korea offers niclosamide-based drug as possible cure for COVID-19 variants

Experimental results have been published for the first time showing that an antiviral drug containing niclosamide, an an...

December 8, 2021 | Wednesday | News
Singapore secures additional supply of mAb sotrovimab for COVID-19 treatment

GlaxoSmithKline (GSK) Singapore has announced an agreement with the Government of Singapore to supply additional doses o...

December 7, 2021 | Tuesday | News
COVID-19: A Crash Course on ‘The Art of Living’!

Most of our life time efforts are bound in securing a good future, but time and again it has been proved that it is not ...

December 6, 2021 | Monday | Opinion
Taiwan explores mix-and-match booster trial of COVID-19 vaccines

The Coalition for Epidemic Preparedness Innovations (CEPI) and Taiwan-based Medigen Vaccine Biologics Corp. (MVC) will c...

December 6, 2021 | Monday | News
Webinar: COVID-19 Molecular Testing – Supporting Back to Life & Work

On-demand webinar is available now Duration: 60 minutes Language: English Platform: Virtual   Key Topics: L...

December 28, 2021 | Tuesday | News
ADB approves $1.5 B for COVID-19 vaccines in India

The Asian Development Bank (ADB) has approved a $1.5 billion loan to help the Government of India purchase safe and effe...

December 1, 2021 | Wednesday | News
US partners with Thailand to combat COVID-19 pandemic

The United States (US) delivered one million life-saving doses of the Moderna mRNA vaccine to help Thailand fight COVID-...

November 26, 2021 | Friday | News
Pakistan receives funding worth $11.7 M for mix-and-match trial of COVID-19 vaccines

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Aga Khan University (AKU) have announced a n...

November 25, 2021 | Thursday | News
Japan finds risk factors associated with waning immunity of Pfizer vaccine

New research from Japan, led by Jichi Medical University, has found several risk factors associated with greater wa...

November 22, 2021 | Monday | News
China's Clover Biopharma receives additional funding for booster dose evaluation

China-based Clover Biopharmaceuticals and Norway-based CEPI, the Coalition for Epidemic Preparedness Innovat...

November 19, 2021 | Friday | News
China's COVID-19 vaccine CoronaVac to be safe for children and adolescents

China-based SINOVAC Biotech has announced that results from blind data analysis of a multi-centre, case-driven, ran...

November 18, 2021 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls